Fenofibrate and Metformin Insulin Sensitivity in Type 2 Diabetics Study
- Conditions
- Type 2 DiabetesDyslipidemia
- Interventions
- First Posted Date
- 2006-08-10
- Last Posted Date
- 2008-08-13
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 8
- Registration Number
- NCT00362765
- Locations
- 🇫🇮
Site 2, Turku, Finland
🇮🇪Site 3, Dublin, Ireland
🇮🇹Site 1, Pisa, Italy
Fenofibrate and Metformin Fixed Combination vs Metformin - FAME METFO
- Conditions
- Dyslipidemia/Glucose Metabolism Disorder
- Interventions
- First Posted Date
- 2006-08-10
- Last Posted Date
- 2010-04-16
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 482
- Registration Number
- NCT00362323
- Locations
- 🇨🇿
C LF23-0121 06 01 Site107, Brno, Czech Republic
🇨🇿C LF23-0121 06 01 Site108, Holesov, Czech Republic
🇨🇿C LF23-0121 06 01 Site101, Karlovy Vary, Czech Republic
Fenofibrate and Metformin Fixed Combination vs Rosiglitazone - FAME ROSI
- Conditions
- DyslipidemiaGlucose Metabolism Disorder
- Interventions
- First Posted Date
- 2006-08-09
- Last Posted Date
- 2008-06-27
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 88
- Registration Number
- NCT00361868
- Locations
- 🇭🇷
Site105, Pula, Croatia
🇭🇷Site102, Rijeka, Croatia
🇭🇷Site103, Split, Croatia
Comparison of the Combination of Fenofibrate and Simvastatin Versus Pravastatin
- First Posted Date
- 2006-08-09
- Last Posted Date
- 2009-07-08
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 423
- Registration Number
- NCT00362206
- Locations
- 🇬🇷
Site 40, Athens, Greece
🇬🇷Site 39, Ioannina, Greece
🇬🇷Site 41, Thessaloniki, Greece
Fluvoxamine Maleate in the Treatment of Obsessive-Compulsive Disorder: A Post-marketing Clinical Study in Children and Adolescents
- Conditions
- Obsessive Compulsive Disorder
- Interventions
- Drug: Placebo
- First Posted Date
- 2006-07-17
- Last Posted Date
- 2010-03-04
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 20
- Registration Number
- NCT00352768
- Locations
- 🇯🇵
S114.3.118 Kohnodai Hospital, National Center of N, Chiba prefecture, Japan
🇯🇵S114.3.118 Kyushu University Hospital, Fukuoka prefecture, Japan
🇯🇵S114.3.118 Hiroshima-city Funairi Hospital, Hiroshima prefecture, Japan
Fluvoxamine Maleate in the Treatment of Depression/Depressive State : A Post-marketing Clinical Study in Children and Adolescents
- Conditions
- Major Depressive Disorder
- Interventions
- Drug: Placebo
- First Posted Date
- 2006-07-17
- Last Posted Date
- 2010-03-04
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 90
- Registration Number
- NCT00353028
- Locations
- 🇯🇵
S114.3.117 Kohnodai Hospital, National Center of N, Chiba prefecture, Japan
🇯🇵S114.3.117 Fukuoka University Hospital, Fukuoka prefecture, Japan
🇯🇵S114.3.117 Hatakeyama Clinic, Fukuoka prefecture, Japan
Comparison of the Combination of Fenofibrate and 40 mg Simvastatin Versus 40 mg Simvastatin Monotherapy
- Conditions
- Cardiovascular Diseases
- Interventions
- First Posted Date
- 2006-07-14
- Last Posted Date
- 2009-07-08
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 450
- Registration Number
- NCT00352183
- Locations
- 🇦🇺
Site 204, Adelaide, Australia
🇦🇺Site 214, Adelaide, Australia
🇦🇺Site 203, Bendigo, Australia
A Controlled-Study on the Effect of a Combination of Fenofibrate and Metformin on Weight Loss and Weight Loss-Maintenance, in Obese Patients.
- Conditions
- Obesity
- First Posted Date
- 2006-07-07
- Last Posted Date
- 2007-09-03
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 148
- Registration Number
- NCT00349635
- Locations
- 🇫🇮
Site 1, Helsinki, Finland
🇫🇮Site 3, Kuopio, Finland
🇫🇮Site 2, Oulu, Finland
Comparison of the Combination of Fenofibrate and 20 mg Simvastatin Versus 40 mg Simvastatin Monotherapy
- First Posted Date
- 2006-07-07
- Last Posted Date
- 2009-07-08
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 1040
- Registration Number
- NCT00349375
- Locations
- 🇨🇿
Site 008, Brno, Czech Republic
🇨🇿Site 009, Brno, Czech Republic
🇨🇿Site 010, Brno, Czech Republic
Acceptability of a Fixed Combination of Fenofibrate and Metformin
- Conditions
- Dyslipidemia/Glucose Metabolism Disorder
- First Posted Date
- 2006-07-06
- Last Posted Date
- 2007-09-03
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 69
- Registration Number
- NCT00348725
- Locations
- 🇫🇷
Site 24, Anzin, France
🇫🇷Site 23, Bachant, France
🇫🇷Site 21, Baune, France